Thyme Care - Robin Shah - Dr Bobby Green - Dr Brad Diephuis

From left: Robin Shah (Thyme co-founder and CEO); Dr. Bobby Green (co-founder, CMO and president; and Dr. Brad Diephuis (president and COO).

 Courtesy of Thyme Care

Nashville-based oncology company Thyme Care has announced a $97 million Series D funding round to support growth in coordinated cancer care.

The late-stage venture capital funding effort was led by current investors CVS Health Ventures, Foresite Capital, a16z Bio + Health, Concord Health Partners, Town Hall Ventures, AlleyCorp and Frist Cressey Ventures, according to a release.

Tags

Recommended for you